Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1350 of 2051 entries
View as:

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

Phase: N/A Priority: Normal
NCT ID: NCT05877547 Org: User:
Start: 06/23/23 End: 12/29/25 Due: 12/29/26

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

Phase: N/A Priority: Normal
NCT ID: NCT04956692 Org: User:
Start: 08/05/21 End: 10/14/26 Due: 10/14/27

Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)

Phase: N/A Priority: Normal
NCT ID: NCT00725010 Org: User:
Start: 04/30/07 End: 04/30/09 Due: 04/30/10

Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00970762 Org: User:
Start: 02/28/03 End: 02/29/04 Due: 02/28/05

MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00372060 Org: User:
Start: 08/21/06 End: 02/05/08 Due: 02/05/09

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO-INFXN (MK-5172-061)

Phase: N/A Priority: Normal
NCT ID: NCT02105662 Org: User:
Start: 06/03/14 End: 05/22/15 Due: 05/22/16

A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)

Phase: N/A Priority: Normal
NCT ID: NCT01034111 Org: User:
Start: 03/01/10 End: 10/04/10 Due: 10/04/11

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)

Phase: N/A Priority: Normal
NCT ID: NCT00686621 Org: User:
Start: - End: - Due: -

Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)

Phase: N/A Priority: Normal
NCT ID: NCT00080444 Org: User:
Start: 04/30/04 End: 03/31/07 Due: 03/31/08

Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00807001 Org: User:
Start: 12/31/08 End: 07/31/09 Due: 07/31/10

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

Phase: N/A Priority: Normal
NCT ID: NCT01229267 Org: User:
Start: 11/30/10 End: 12/23/15 Due: 12/23/16

A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)

Phase: N/A Priority: Normal
NCT ID: NCT06698016 Org: User:
Start: 07/25/23 End: 10/30/23 Due: 10/30/24

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT04889118 Org: User:
Start: 07/14/20 End: 11/01/24 Due: 11/01/25

A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)

Phase: N/A Priority: Normal
NCT ID: NCT02775435 Org: User:
Start: 06/09/16 End: 09/14/23 Due: 09/14/24

Observational Data Analysis in EuroSIDA (MK-0518-058)

Phase: N/A Priority: Normal
NCT ID: NCT01078233 Org: User:
Start: 05/05/08 End: 03/06/14 Due: 03/06/15

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Phase: N/A Priority: Normal
NCT ID: NCT01414166 Org: User:
Start: 09/30/11 End: 02/28/13 Due: 02/28/14

Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)

Phase: N/A Priority: Normal
NCT ID: NCT01106287 Org: User:
Start: 10/31/09 End: 03/31/10 Due: 03/31/11

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

Phase: N/A Priority: Normal
NCT ID: NCT00542022 Org: User:
Start: 06/30/04 End: 05/31/05 Due: 05/31/06

Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002)

Phase: N/A Priority: Normal
NCT ID: NCT02161510 Org: User:
Start: 07/31/14 End: 04/30/15 Due: 04/30/16

A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01446003 Org: User:
Start: 10/25/11 End: 03/03/12 Due: 03/03/13

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Phase: N/A Priority: Normal
NCT ID: NCT00002179 Org: User:
Start: - End: - Due: -

Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)

Phase: N/A Priority: Normal
NCT ID: NCT00846781 Org: User:
Start: 02/28/09 End: 02/28/11 Due: 02/28/12

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)

Phase: N/A Priority: Normal
NCT ID: NCT03820986 Org: User:
Start: 03/12/19 End: 11/01/24 Due: 11/01/25

MARS - Monitored Atherosclerosis Regression Study

Phase: N/A Priority: Normal
NCT ID: NCT00116870 Org: User:
Start: 06/30/85 End: 02/29/92 Due: 02/28/93

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Phase: N/A Priority: Normal
NCT ID: NCT00886613 Org: User:
Start: 03/31/09 End: 12/31/09 Due: 12/31/10